NCT05559008 2022-11-09A Umbrella Study in R/R PTCL Guided by Molecular SubtypesRuijin HospitalPhase 1/2 Unknown116 enrolled
NCT04476459 2021-03-15Camrelizumab in Combination With Apatinib in Refractory and Relapsed DLBCLSun Yat-sen UniversityPhase 1/2 Unknown33 enrolled
NCT02844881 2016-08-11Study of Apatinib and MASCT in Patients With Advanced Solid TumorsThe First People's Hospital of LianyungangPhase 1/2 Unknown60 enrolled